| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
University Medical
School of Pécs, Hungary, and the Department of
Pathology,
Weill Medical College of Cornell
University, New York, New York
Primary effusion lymphoma (PEL) is a recently described distinct subtype of non-Hodgkin's lymphoma associated with infection by the Kaposi's sarcoma-associated herpesvirus, also called human herpesvirus-8. Most cases of PEL are also associated with the Epstein-Barr virus (EBV). In order to better characterize the cellular origin of PEL, we investigated the immunoglobulin (Ig) heavy chain variable region (VH) genes expressed by tumor cells of the BC-1 and BC-3 cell lines derived from PELs and five original PEL specimens. In the six EBV-positive PELs examined, including the BC-1 cell line, the expressed VH gene sequences showed numerous point mutations relative to the putative germline VH gene sequences. In addition, the VH segment of one of these cases showed intraclonal sequence heterogeneity, indicating ongoing somatic mutation. In five cases, the distribution and type of mutations indicated that tumor cells had been selected by antigen. Because somatically mutated Ig genes are expressed by B cells that have reached a germinal center/post-germinal center stage of development, these findings suggest that the PEL cell of origin is a germinal center or post-germinal center B cell in most cases. In contrast, the VH gene segment expressed by tumor cells of the BC-3 cell line, which was originated from an EBV-negative PEL obtained from an HIV-negative patient, was unmutated, suggesting a pre-germinal center B cell origin for tumor cells of this particular PEL cell line. Taken together, these findings suggest that development of PELs may not be restricted to one stage of B cell differentiation and may represent transformation of B cells at different stages of ontogeny.
This article has been cited by other articles:
![]() |
S. J. Wilson, E. H. Tsao, B. L. J. Webb, H. Ye, L. Dalton-Griffin, C. Tsantoulas, C. V. Gale, M.-Q. Du, A. Whitehouse, and P. Kellam X Box Binding Protein XBP-1s Transactivates the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) ORF50 Promoter, Linking Plasma Cell Differentiation to KSHV Reactivation from Latency J. Virol., December 15, 2007; 81(24): 13578 - 13586. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Skalsky, M. A. Samols, K. B. Plaisance, I. W. Boss, A. Riva, M. C. Lopez, H. V. Baker, and R. Renne Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155 J. Virol., December 1, 2007; 81(23): 12836 - 12845. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-Q Du, C M Bacon, and P G Isaacson Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders J. Clin. Pathol., December 1, 2007; 60(12): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-B. Chen, A. Rahemtullah, and E. Hochberg Primary Effusion Lymphoma Oncologist, May 1, 2007; 12(5): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arguello, S. Paz, E. Hernandez, C. Corriveau-Bourque, L. M. Fawaz, J. Hiscott, and R. Lin Leukotriene A4 Hydrolase Expression in PEL Cells Is Regulated at the Transcriptional Level and Leads to Increased Leukotriene B4 Production. J. Immunol., June 1, 2006; 176(11): 7051 - 7061. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fan, D. Bubman, A. Chadburn, W. J. Harrington Jr., E. Cesarman, and D. M. Knowles Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association J. Virol., January 15, 2005; 79(2): 1244 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Alexandrakis, F. H. Passam, D. S. Kyriakou, and D. Bouros Pleural Effusions in Hematologic Malignancies Chest, April 1, 2004; 125(4): 1546 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Trivedi, K. Takazawa, C. Zompetta, L. Cuomo, E. Anastasiadou, A. Carbone, S. Uccini, F. Belardelli, K. Takada, L. Frati, et al. Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression Blood, January 1, 2004; 103(1): 313 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Jenner, K. Maillard, N. Cattini, R. A. Weiss, C. Boshoff, R. Wooster, and P. Kellam Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile PNAS, September 2, 2003; 100(18): 10399 - 10404. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Klein, A. Gloghini, G. Gaidano, A. Chadburn, E. Cesarman, R. Dalla-Favera, and A. Carbone Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts Blood, May 15, 2003; 101(10): 4115 - 4121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Gordon, C. M. Kanegai, J. R. Doerr, and R. Wall Somatic hypermutation of the B cell receptor genes B29 (Igbeta , CD79b) and mb1 (Igalpha , CD79a) PNAS, April 1, 2003; 100(7): 4126 - 4131. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. French, C. S. Malone, R. R. Shen, M. Renard, S. E. Henson, M. D. Miner, R. Wall, and M. A. Teitell Sp1 Transactivation of the TCL1 Oncogene J. Biol. Chem., January 3, 2003; 278(2): 948 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Q. Du, T. C. Diss, H. Liu, H. Ye, R. A. Hamoudi, J. Cabecadas, H. Y. Dong, N. L. Harris, J. K. C. Chan, J. W. Rees, et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder Blood, October 16, 2002; 100(9): 3415 - 3418. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Ablashi, L. G. Chatlynne, J. E. Whitman Jr., and E. Cesarman Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases Clin. Microbiol. Rev., July 1, 2002; 15(3): 439 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oksenhendler, E. Boulanger, L. Galicier, M.-Q. Du, N. Dupin, T. C. Diss, R. Hamoudi, M.-T. Daniel, F. Agbalika, C. Boshoff, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease Blood, April 1, 2002; 99(7): 2331 - 2336. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Kamnasaran and D W Cox Current status of human chromosome 14 J. Med. Genet., February 1, 2002; 39(2): 81 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Perez and S. Rudoy Anti-CD20 Monoclonal Antibody Treatment of Human Herpesvirus 8-Associated, Body Cavity-Based Lymphoma with an Unusual Phenotype in a Human Immunodeficiency Virus-Negative Patient Clin. Vaccine Immunol., September 1, 2001; 8(5): 993 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Malone, M. D. Miner, J. R. Doerr, J. P. Jackson, S. E. Jacobsen, R. Wall, and M. Teitell CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing PNAS, August 10, 2001; (2001) 181206898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Q. Du, H. Liu, T. C. Diss, H. Ye, R. A. Hamoudi, N. Dupin, V. Meignin, E. Oksenhendler, C. Boshoff, and P. G. Isaacson Kaposi sarcoma-associated herpesvirus infects monotypic (IgM{lambda}) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders Blood, April 1, 2001; 97(7): 2130 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krithivas, D. B. Young, G. Liao, D. Greene, and S. D. Hayward Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells J. Virol., October 15, 2000; 74(20): 9637 - 9645. [Abstract] [Full Text] |
||||
![]() |
F. Pica, A. Volpi, A. Serafino, M. Fraschetti, O. Franzese, and E. Garaci Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells Blood, May 1, 2000; 95(9): 2905 - 2912. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dupin, T. L. Diss, P. Kellam, M. Tulliez, M.-Q. Du, D. Sicard, R. A. Weiss, P. G. Isaacson, and C. Boshoff HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma Blood, February 15, 2000; 95(4): 1406 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Muller-Hermelink and A. Greiner Molecular Analysis of Human Immunoglobulin Heavy Chain Variable Genes (IgVH) in Normal and Malignant B Cells Am. J. Pathol., November 1, 1998; 153(5): 1341 - 1346. [Full Text] [PDF] |
||||
![]() |
C. S. Malone, M. D. Miner, J. R. Doerr, J. P. Jackson, S. E. Jacobsen, R. Wall, and M. Teitell CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing PNAS, August 28, 2001; 98(18): 10404 - 10409. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |